Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized, and biological formats; and Fosfomycin trometamol under the Fosfomicina Labiana brand name. In addition, the company offers contract developments and manufacturing services. Labiana Health S.A. was founded in 1958 and is based in Pozuelo de Alarcón, Spain.
Metrics to compare | LABH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLABHPeersSector | |
---|---|---|---|---|
P/E Ratio | −15.5x | −3.6x | −0.6x | |
PEG Ratio | −0.20 | 0.02 | 0.00 | |
Price/Book | 3.9x | 0.9x | 2.6x | |
Price / LTM Sales | 0.3x | 2.1x | 3.1x | |
Upside (Analyst Target) | −17.2% | 51.7% | 55.4% | |
Fair Value Upside | Unlock | 10.3% | 10.2% | Unlock |